As a Senior Director on UTIMCO’s investment team, Pat maintains responsibility for leading the healthcare and developed country private equity strategies. He joined UTIMCO after working with EDG Partners as an Advisor. Previously, Pat served as Managing Director at Citadel Investment Group. Prior to Citadel, he led healthcare high yield and distressed debt investing as part of AIG Investments, served as a Senior Analyst covering the medical device industry at UBS, and worked in Equities at Credit Suisse First Boston. Dr. Pace began his career as a resident in Otolaryngology (ENT) at the University of Virginia Hospital.
Dr. Pace serves on the boards of MMIS, Inc, and Encision (ECIA), as well as Executive Chairman of Nanospectra Biosciences. He serves on the Advisory Council for the UT-Health School of Biomedical Informatics and on the Investment Committee for the Seton Fund. Pat received a Bachelor of Arts, with Honors in Psychology, from Vanderbilt University and a Doctor of Medicine from The University of Texas Medical School at Houston.